Whan In Pharm Statistics

Total Valuation

Whan In Pharm has a market cap or net worth of KRW 174.04 billion. The enterprise value is 121.88 billion.

Market Cap	174.04B
Enterprise Value	121.88B

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Whan In Pharm has 15.27 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	15.27M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.36%
Owned by Institutions (%)	18.64%
Float	10.94M

Valuation Ratios

The trailing PE ratio is 7.44 and the forward PE ratio is 8.62.

PE Ratio	7.44
Forward PE	8.62
PS Ratio	0.67
PB Ratio	0.46
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	8.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.81, with an EV/FCF ratio of -18.29.

EV / Earnings	5.21
EV / Sales	0.47
EV / EBITDA	3.81
EV / EBIT	5.19
EV / FCF	-18.29

Financial Position

The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.00.

Current Ratio	4.75
Quick Ratio	3.03
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	-0.06
Interest Coverage	929.61

Financial Efficiency

Return on equity (ROE) is 6.37% and return on invested capital (ROIC) is 3.65%.

Return on Equity (ROE)	6.37%
Return on Assets (ROA)	3.25%
Return on Invested Capital (ROIC)	3.65%
Return on Capital Employed (ROCE)	5.62%
Revenue Per Employee	446.04M
Profits Per Employee	40.17M
Employee Count	582
Asset Turnover	0.63
Inventory Turnover	2.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.15% in the last 52 weeks. The beta is 0.32, so Whan In Pharm's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-17.15%
50-Day Moving Average	11,396.20
200-Day Moving Average	12,738.35
Relative Strength Index (RSI)	54.92
Average Volume (20 Days)	14,994

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Whan In Pharm had revenue of KRW 259.60 billion and earned 23.38 billion in profits. Earnings per share was 1,531.45.

Revenue	259.60B
Gross Profit	93.66B
Operating Income	21.50B
Pretax Income	26.95B
Net Income	23.38B
EBITDA	29.97B
EBIT	21.50B
Earnings Per Share (EPS)	1,531.45

Full Income Statement

Balance Sheet

The company has 52.58 billion in cash and 413.74 million in debt, giving a net cash position of 52.17 billion or 3,416.99 per share.

Cash & Cash Equivalents	52.58B
Total Debt	413.74M
Net Cash	52.17B
Net Cash Per Share	3,416.99
Equity (Book Value)	376.00B
Book Value Per Share	24,628.27
Working Capital	158.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.69 billion and capital expenditures -27.36 billion, giving a free cash flow of -6.66 billion.

Operating Cash Flow	20.69B
Capital Expenditures	-27.36B
Free Cash Flow	-6.66B
FCF Per Share	-436.48

Full Cash Flow Statement

Margins

Gross margin is 36.08%, with operating and profit margins of 8.28% and 9.01%.

Gross Margin	36.08%
Operating Margin	8.28%
Pretax Margin	10.38%
Profit Margin	9.01%
EBITDA Margin	11.54%
EBIT Margin	8.28%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.64%.

Dividend Per Share	300.00
Dividend Yield	2.64%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	19.59%
Buyback Yield	n/a
Shareholder Yield	2.64%
Earnings Yield	13.43%
FCF Yield	-3.83%

Dividend Details

Stock Splits

The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.

Last Split Date	Apr 14, 2010
Split Type	Forward
Split Ratio	2

Scores

Whan In Pharm has an Altman Z-Score of 5.03.

Altman Z-Score	5.03
Piotroski F-Score	n/a